These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 3064426)

  • 21. Comparison of the ability of formalin-inactivated respiratory syncytial virus, immunopurified F, G and N proteins and cell lysate to enhance pulmonary changes in Balb/c mice.
    Vaux-Peretz F; Chapsal JM; Meignier B
    Vaccine; 1992; 10(2):113-8. PubMed ID: 1539464
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recombinant bovine/human parainfluenza virus type 3 (B/HPIV3) expressing the respiratory syncytial virus (RSV) G and F proteins can be used to achieve simultaneous mucosal immunization against RSV and HPIV3.
    Schmidt AC; McAuliffe JM; Murphy BR; Collins PL
    J Virol; 2001 May; 75(10):4594-603. PubMed ID: 11312329
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systemic and mucosal immunity to respiratory syncytial virus induced by recombinant Streptococcus gordonii surface-displaying a domain of viral glycoprotein G.
    Falcone V; Mihm D; Neumann-Haefelin D; Costa C; Nguyen T; Pozzi G; Ricci S
    FEMS Immunol Med Microbiol; 2006 Oct; 48(1):116-22. PubMed ID: 16965359
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bovine respiratory syncytial virus-specific immune responses in cattle following immunization with modified-live and inactivated vaccines. Analysis of proliferation and secretion of lymphokines by leukocytes in vitro.
    Ellis JA; Belden EL; Haven TR; Cavender J
    Vet Immunol Immunopathol; 1992 Oct; 34(1-2):21-34. PubMed ID: 1441227
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Respiratory syncytial virus: virology, diagnosis, and vaccination.
    Toms GL
    Lung; 1990; 168 Suppl():388-95. PubMed ID: 1696677
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunosuppression of the antibody response to respiratory syncytial virus (RSV) by pre-existing serum antibodies: partial prevention by topical infection of the respiratory tract with vaccinia virus-RSV recombinants.
    Murphy BR; Collins PL; Lawrence L; Zubak J; Chanock RM; Prince GA
    J Gen Virol; 1989 Aug; 70 ( Pt 8)():2185-90. PubMed ID: 2671259
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serious respiratory tract disease caused by respiratory syncytial virus: prospects for improved therapy and effective immunization.
    Chanock RM; Parrott RH; Connors M; Collins PL; Murphy BR
    Pediatrics; 1992 Jul; 90(1 Pt 2):137-43. PubMed ID: 1603639
    [No Abstract]   [Full Text] [Related]  

  • 28. Development of a novel subunit vaccine that protects cotton rats against both human respiratory syncytial virus and human parainfluenza virus type 3.
    Homa FL; Brideau RJ; Lehman DJ; Thomsen DR; Olmsted RA; Wathen MW
    J Gen Virol; 1993 Sep; 74 ( Pt 9)():1995-9. PubMed ID: 8397289
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunopathologic mechanisms in lower respiratory tract disease of infants due to respiratory syncytial virus.
    McIntosh K; Fishaut JM
    Prog Med Virol; 1980; 26():94-118. PubMed ID: 6999535
    [No Abstract]   [Full Text] [Related]  

  • 30. Live-attenuated virus vaccines for respiratory syncytial and parainfluenza viruses: applications of reverse genetics.
    Murphy BR; Collins PL
    J Clin Invest; 2002 Jul; 110(1):21-7. PubMed ID: 12093883
    [No Abstract]   [Full Text] [Related]  

  • 31. [Evaluation of serological examination in the diagnosis of RS virus infection in infants].
    Jankowski M; Wilczyński J; Styczyński P; Torbicka E; Tranda I
    Med Dosw Mikrobiol; 1988; 40(3):167-72. PubMed ID: 3246919
    [No Abstract]   [Full Text] [Related]  

  • 32. Prospects for a respiratory syncytial virus vaccine.
    Hall CB
    Science; 1994 Sep; 265(5177):1393-4. PubMed ID: 7915433
    [No Abstract]   [Full Text] [Related]  

  • 33. Respiratory syncytial virus vaccines.
    Karron RA; Ambrosino DM
    Pediatr Infect Dis J; 1998 Oct; 17(10):919-20. PubMed ID: 9802636
    [No Abstract]   [Full Text] [Related]  

  • 34. Vaccination against respiratory syncytial virus: problems and progress.
    Toms GL
    FEMS Microbiol Immunol; 1991 Oct; 3(5):243-56. PubMed ID: 1797047
    [No Abstract]   [Full Text] [Related]  

  • 35. Current approaches to the development of vaccines effective against parainfluenza and respiratory syncytial viruses.
    Murphy BR; Prince GA; Collins PL; Van Wyke Coelingh K; Olmsted RA; Spriggs MK; Parrott RH; Kim HW; Brandt CD; Chanock RM
    Virus Res; 1988 Aug; 11(1):1-15. PubMed ID: 2845680
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunoblot analysis of the human antibody response to respiratory syncytial virus infection.
    Gimenez HB; Keir HM; Cash P
    J Gen Virol; 1987 May; 68 ( Pt 5)():1267-75. PubMed ID: 3572364
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Parenteral immunization with live respiratory syncytial virus is blocked in seropositive cotton rats.
    Prince GA; Horswood RL; Camargo E; Suffin SC; Chanock RM
    Infect Immun; 1982 Sep; 37(3):1074-8. PubMed ID: 6752019
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effect of the humoral immune response on the pathogenesis of respiratory syncytial virus (RSV) infection].
    Streckert HJ; Humbert B; Philippou S; Forster J
    Immun Infekt; 1993 Jun; 21(3):75-7. PubMed ID: 8335338
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vaccine studies with the 32H reisolate of SIVmac251: an overview.
    Cranage M; Stott J; Mills K; Ashworth T; Taffs F; Farrar G; Chan L; Dennis M; Putkonen P; Biberfeld G
    AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1479-81. PubMed ID: 1466987
    [No Abstract]   [Full Text] [Related]  

  • 40. [Immunization against HIV. Problems in developing a vaccine].
    Uhl D
    Med Monatsschr Pharm; 1988 Nov; 11(11):376-8. PubMed ID: 3059163
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.